Summit Therapeutics

Summit Therapeutics Gross Margin

The Gross Margin of Summit Therapeutics (SMMT) as of Nov 22, 2026 is 75.30 %. In the previous year, Gross Margin was 76.34 % — a change of -1.35% (lower).

Gross Margin

75.30 %

YoY

-1.35%

Last updated:

Gross Margin of Summit Therapeutics is 2018 75.30 % . Gross Margin of Summit Therapeutics was 2017 76.34 % . It decreases by -1.35% lower compared to the previous year.

Summit Therapeutics's gross margin stands at 75.3%, down from 100.0% several years earlier.

The Summit Therapeutics Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2007
0.58 USD
Jan 1, 2008
0.95 USD
Jan 1, 2009
1.00 USD
Jan 1, 2010
1.00 USD
Jan 1, 2011
1.00 USD
Jan 1, 2012
1.00 USD
Jan 1, 2017
76.34 USD
Jan 1, 2018
75.30 USD
The Summit Therapeutics Gross Margin history
YEARGross MarginYoY
75.30 %-1.35%
76.34 %+7,533.54%
1.00 %0.00%
1.00 %0.00%
1.00 %0.00%
1.00 %+5.56%
0.95 %+62.18%
0.58 %-17.58%
0.71 %+25.21%
0.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Gross Margin of Summit Therapeutics is 75.30 % in 2018.

Gross Margin of Summit Therapeutics changed from 76.34 % to 75.30 %, representing a -1.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Summit Therapeutics

All Key Metrics — Summit Therapeutics